AA
TECX

AlphaCentric Advisors’s Tectonic Therapeutic TECX Stock Holding History

AlphaCentric Advisors’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Buy
6,849
+373
+6% +$9.18K 0.21% 139
2025
Q4 		$135K Buy
+6,476
New +$120K 0.13% 185
2021
Q1 		– Sell
-1,475
Closed -$247K – 221
2020
Q4 		$247K Buy
+1,475
New +$262K 0.1% 55

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

AlphaCentric Advisors's TECX Position: Q1 2026 in Review

AlphaCentric Advisors increased its Tectonic Therapeutic (TECX) stake by 5.8% in Q1 2026, buying an estimated $9.18K and bringing the position to 6,849 shares worth $212K. The position accounts for 0.21% of the portfolio, ranked #139.

AlphaCentric Advisors first reported a position in TECX in Q4 2020 and has held it in 3 quarters since. The position peaked at $247K in Q4 2020. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • AlphaCentric Advisors held 6,849 shares of Tectonic Therapeutic worth $212K as of Q1 2026.
  • AlphaCentric Advisors bought 373 Tectonic Therapeutic shares in Q1 2026, an estimated $9.18K.
  • Tectonic Therapeutic made up 0.21% of AlphaCentric Advisors's portfolio in Q1 2026, its #139 holding.
  • AlphaCentric Advisors first reported a position in Tectonic Therapeutic in Q4 2020 and has held it in 3 quarters since.
  • AlphaCentric Advisors's Tectonic Therapeutic position peaked at $247K in Q4 2020.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.